ORAMED PHARMACEUTICALS INC

$ORMP
Institutional coverage

61 13F filers hold $ORMP.

13F holders
61
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

3 holders · Q1 2026

$ORMP is held by 3 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.00%, with an average of 0.00% of portfolio. Largest holder: Knightsbridge Asset Management, LLC at 0.00%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 61 · Source: 13F-HR
01
Leigh Baldwin & Co. LLC
0.53% of portfolio
4,224,624 sh
02
Archford Capital Strategies, LLC
6.91% of portfolio
3,167,231 sh
03
Aquamarine Financial (Cayman) Ltd
0.46% of portfolio
1,973,057 sh
04
Legal & General Group Plc
0.01% of portfolio
1,910,540 sh
05
Fwl Investment Management, LLC
0.70% of portfolio
1,315,294 sh
06
Callan Capital, LLC
0.03% of portfolio
1,201,432 sh
07
State Farm Mutual Automobile Insurance Co.
311,172 sh
08
Minneapolis Portfolio Management Group, LLC
259,611 sh
09
Brightline Capital Management, LLC
249,482 sh
10
Rathbones Group PLC
233,018 sh
See all 61 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $ORMP in the recent window.

Congress trades · last 90 days

1 disclosures · STOCK Act
House · North Carolina · Traded Jan 10
SOLD
$15K–$50K
Feb 25STOCK

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 10:00 UTC.